Chris Cline | SVP, IR & Corporate Communications |
Eric Dube | CEO |
Noah Rosenberg | CMO |
Peter Heerma | CCO |
Laura Clague | CFO |
Bill Rote | SVP, Research & Development |
Maury Raycroft | Jefferies |
Greg Harrison | Bank of America |
Joseph Schwartz | SVB Leerink |
Michelle Gilson | Canaccord Genuity |
Liisa Bayko | Evercore ISI |
Laura Chico | Wedbush Securities |
Good day and thank you for standing by and welcome to the Travere Therapeutics' Third Quarter 2021 Financial Results and Corporate Update Call. At this time, all participants are in a listen-only mode. Please be advised that this call is being recorded. [Operator Instructions] I would now like to hand the conference over to Mr. Chris Cline, Senior Vice President, Investor Relations and Corporate Communication.